Decreased plasma membrane expression of striatal dopamine transporter in aging
暂无分享,去创建一个
Greg A. Gerhardt | S. Apparsundaram | G. Gerhardt | Subbu Apparsundaram | Michael F. Salvatore | M. F. Salvatore
[1] E. Krebs,et al. Association of mitogen-activated protein kinase with the microtubule cytoskeleton. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[2] Yu Wang,et al. Protein kinase‐mediated bidirectional trafficking and functional regulation of the human dopamine transporter , 1998, Synapse.
[3] R. Blakely,et al. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. , 1996, Molecular pharmacology.
[4] G. Gerhardt,et al. Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys , 2002, Journal of neurochemistry.
[5] Patrick R. Hof,et al. Functional neurobiology of aging , 2001 .
[6] Greg A. Gerhardt,et al. Age-related changes in potassium-evoked overflow of dopamine in the striatum of the rhesus monkey , 1995, Neurobiology of Aging.
[7] G. Gerhardt,et al. Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats , 1998, Brain Research.
[8] Michael J. Bannon,et al. Age‐related and regional differences in dopamine transporter mRNA expression in human midbrain , 1997, Neurology.
[9] J. Haycock,et al. Striatal 3,4‐dihydroxyphenylalanine decarboxylase in aging: Disparity between postmortem and positron emission tomography studies? , 1995, Annals of neurology.
[10] G. Gerhardt,et al. Differences in pharmacological properties of dopamine release between the substantia nigra and striatum: an in vivo electrochemical study. , 1999, The Journal of pharmacology and experimental therapeutics.
[11] N. Zahniser,et al. Chronic and acute regulation of Na+/Cl- -dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. , 2001, Pharmacology & therapeutics.
[12] N. Morel,et al. VAMP (synaptobrevin) is present in the plasma membrane of nerve terminals. , 1999, Journal of cell science.
[13] M. Rice,et al. Novel Ca2+ Dependence and Time Course of Somatodendritic Dopamine Release: Substantia Nigra versus Striatum , 2001, The Journal of Neuroscience.
[14] J. Haycock. Quantitation of tyrosine hydroxylase, protein levels: spot immunolabeling with an affinity-purified antibody. , 1989, Analytical biochemistry.
[15] J. Holden,et al. Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys , 1998, The Journal of comparative neurology.
[16] G. Gerhardt,et al. Age-related reductions in [3H]WIN 35,428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the fischer 344 rat. , 1999, The Journal of pharmacology and experimental therapeutics.
[17] D. Mash,et al. Dopamine transporter‐immunoreactive neurons decrease with age in the human substantia nigra , 1999, The Journal of comparative neurology.
[18] H. Melikian,et al. Membrane Trafficking Regulates the Activity of the Human Dopamine Transporter , 1999, The Journal of Neuroscience.
[19] N. Zahniser,et al. Protein tyrosine kinase inhibitors alter human dopamine transporter activity in Xenopus oocytes. , 2001, The Journal of pharmacology and experimental therapeutics.
[20] L A Beckett,et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. , 1996, The New England journal of medicine.
[21] S J Kish,et al. Biochemical pathophysiology of Parkinson's disease. , 1987, Advances in neurology.
[22] Janet R. Saffer,et al. Effects of age on dopamine transporters in healthy humans. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] S. Amara,et al. Regulated Trafficking of the Human Dopamine Transporter , 1999, The Journal of Biological Chemistry.
[24] M. Kuhar,et al. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[25] N. Volkow,et al. Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging , 1998, Annals of neurology.
[26] G. Uhl,et al. Protein Kinase C-mediated Phosphorylation and Functional Regulation of Dopamine Transporters in Striatal Synaptosomes* , 1997, The Journal of Biological Chemistry.
[27] A. Deutch,et al. Stoichiometry of Tyrosine Hydroxylase Phosphorylation in the Nigrostriatal and Mesolimbic Systems In Vivo , 2000, Journal of neurochemistry.
[28] G. Gerhardt,et al. Biochemical and Anatomical Changes in Basal Ganglia of Aging Animals , 2001 .
[29] N. Zahniser,et al. Brief, repeated exposure to substrates down‐regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo , 2002, Journal of neurochemistry.
[30] R. Blakely,et al. Biogenic amine transporters: regulation in flux , 2000, Current Opinion in Neurobiology.
[31] R. Blakely,et al. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. , 1998, The Journal of pharmacology and experimental therapeutics.
[32] G. Gerhardt,et al. Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study. , 1999, The Journal of pharmacology and experimental therapeutics.
[33] M. Wolf,et al. Effect of Aging on Tyrosine Hydroxylase Protein Content and the Relative Number of Dopamine Nerve Terminals in Human Caudate , 1991, Journal of neurochemistry.
[34] M. Bannon,et al. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] Marc G Caron,et al. Monoamine transporters: from genes to behavior. , 2003, Annual review of pharmacology and toxicology.
[36] Y. Agid,et al. Preservation of midbrain catecholaminergic neurons in very old human subjects. , 2000, Brain : a journal of neurology.
[37] K. Vrana,et al. Regulation of Rat Dopamine Transporter mRNA and Protein by Chronic Cocaine Administration , 1999, Journal of neurochemistry.
[38] J. Marcusson,et al. Age-correlated loss of dopamine uptake sites labeled with [3H]GBR-12935 in human putamen , 1989, Neurobiology of Aging.
[39] J. Scheys,et al. Cocaine induction of dopamine transporter trafficking to the plasma membrane. , 2002, Molecular pharmacology.
[40] G. Gerhardt,et al. Regional effects of aging on dopaminergic function in the Fischer-344 rat , 1992, Neurobiology of Aging.
[41] G. Gerhardt,et al. Microdialysis studies of basal levels and stimulus-evoked overflow of dopamine and metabolites in the striatum of young and aged Fischer 344 rats , 1999, Brain Research.